Bausch Health Files Q1 2025 10-Q

Ticker: BHC · Form: 10-Q · Filed: May 1, 2025 · CIK: 885590

Sentiment: neutral

Topics: 10-Q, pharmaceuticals, financials

TL;DR

**Bausch Health Q1 2025 10-Q filed. Check financials.**

AI Summary

Bausch Health Companies Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Valeant Pharmaceuticals International, Inc., is based in Laval, Quebec, and operates in the pharmaceutical preparations sector. The filing covers the first quarter of 2025, with financial data reported as of March 31, 2025.

Why It Matters

This filing provides investors with the latest financial performance and operational details for Bausch Health Companies Inc. during the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Bausch Health is subject to regulatory, litigation, and market risks inherent in the industry.

Key Numbers

Key Players & Entities

FAQ

What is the primary business segment of Bausch Health Companies Inc.?

Bausch Health Companies Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.

When was the company formerly known as Valeant Pharmaceuticals International, Inc.?

The company was formerly known as Valeant Pharmaceuticals International, Inc. before a name change.

What is the fiscal year end for Bausch Health Companies Inc.?

The fiscal year end for Bausch Health Companies Inc. is December 31st.

What is the business address of Bausch Health Companies Inc.?

The business address is 2150 St. Elzear Blvd. West, Laval, Quebec, H7L 4A8.

What SEC Act does this 10-Q filing fall under?

This 10-Q filing is made under the Securities Exchange Act of 1934.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding Bausch Health Companies Inc. (BHC).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing